DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Ubicación actual:
>
>
> This Story

Forward Printable StoryPrint Comment

 

 

Alzheimers/Neurology Homepage

Patient-centered visual aid helps physicians discuss risks, treatments with parents

Bittium exhibits SafeMove remote access software along with telehealth and medical monitoring solutions at HETT Show 2018

FDA clears augmented reality visualization solution, GLOW800

New method enables accurate diagnosis of Alzheimer's disease

Novel strategy shows promise for earlier detection of Alzheimer's disease

CDC releases guideline to improve care of children with mild traumatic brain injury

Global Kinetics Corporation hits clinical milestones in its goal to revolutionize Parkinson’s treatment

Yale marries imaging and genetics, opens new view of brain function

Precision Innovation Network (PIN) selects Splice Machine to be data platform for machine learning neurological treatment

Artificial intelligence platform screens for acute neurological illnesses at Mount Sinai

New computational tool could help optimize treatment of Alzheimer's disease

Press releases may be edited for formatting or style
Scientists have developed a novel computational approach that incorporates individual patients' brain activity to calculate optimal, personalized brain stimulation treatment for Alzheimer's disease. Lazaro Sanchez-Rodriguez of the University of Calgary, Canada, and colleagues present their new framework in PLOS Computational Biology.

Electrical stimulation of certain parts of the brain could help promote healthy activity in neural circuits impaired by Alzheimer's disease, a neurodegenerative condition. This experimental treatment has shown some promise in clinical trials. However, all patients currently receive identical treatment protocols, potentially leading to different outcomes according to individual variations in brain signaling.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



To investigate the possibility of personalized brain stimulation, Sanchez-Rodriguez and colleagues took a theoretical approach. They built a computational tool that incorporates patients' MRI scans and physiological brain signaling measurements to calculate optimal brain stimulation signals, with the goal of delivering efficient, effective personalized treatment.

The new approach is based on a computational strategy known as the state-dependent Riccati equation control (SDRE), which has been applied in other fields--such as aerospace engineering--to optimize input signals that control dynamic, nonlinear systems like the human brain. This strategy enabled the new tool to identify specific brain regions that would not benefit from brain stimulation.

The researchers also used their new framework to show that certain parts of the brain, the limbic system and basal ganglia structures, could serve as particularly powerful targets for brain stimulation in Alzheimer's disease. Moreover, they found that patients whose neural structures are highly integrated in the brain network may be the most suitable candidates for stimulation.

"With our new framework, we are getting closer to erasing the knowledge gap between theory and application in brain stimulation," Sanchez-Rodriguez says. "I think we will soon see a boom in the application of our framework and similar tools to study other diseases involving impaired brain activity, such as epilepsy and Parkinson's."

Next, the researchers plan to refine their tool so that it accounts for additional variation in brain activity between patients. The approach will need to be tested in animals before it enters clinical trials.
  Pages: 1 - 2 - 3 >>

Alzheimers/Neurology Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Directorio
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Trabajos/Entrenamiento
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2018 DOTmed.com, Inc.
TODOS LOS DERECHOS RESERVADOS